/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

HC Wainwright & Co. analyst Patrick R. Trucchio downgrades AtaiBeckley (NASDAQ:ATAI) from Buy

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

Lulu's Fashion Lounge Holdings (NASDAQ:LVLU) retained Solomon Partners as its financial advisor and

Deal Dispatch features companies for sale or bought — also off the block — and what bankruptcies are

LLY agrees to acquire AtaiBeckley for $2.8B upfront to expand its neuroscience pipeline with psyched

Top Wall Street analysts changed outlook on top names. Check full changes on analyst ratings page. O

Compass Pathways (NASDAQ:CMPS)'s COMP360 treatment model may face fewer regulatory hurdles as new Ph

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC)'s acquisition by Eli Lilly for up to $3.8 billion reinforc

Jefferies analyst Andrew Tsai downgrades AtaiBeckley (NASDAQ:ATAI) from Buy to Hold and lowers th

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan

AtaiBeckley is developing a promising depression treatment. Eli Lilly has long been a leader in neur

Today, July 16, 2026, the clinical-stage psychedelics developer jumped 33% after Lilly announced a c

Canaccord Genuity analyst Sumant Kulkarni downgrades AtaiBeckley (NASDAQ:ATAI) from Buy to Hold a

NEW YORK, July 16, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & As

AtaiBeckley (ATAI) shares are ripping higher on Thursday morning after pharmaceutical giant Eli Lill

CNBC pharma reporter Angelica Peebles broke down the biggest psychedelics deal in Big Pharma history

Gainers Liminatus Pharma (NASDAQ:LIMN) stock moved upwards by 55.6% to $0.18 during Thursday's

GH Research and Definium Therapeutics stocks rose after Eli Lilly agreed to buy AtaiBeckley in a dea

Eli Lilly and Co (NYSE:LLY) on Thursday agreed to acquire AtaiBeckley Inc. (NASDAQ:ATAI) in a deal t

Lilly will acquire AtaiBeckley in a deal worth up to $3.8 billion, adding late-stage depression ther

4:15pm: Semiconductor selloff Wall Street ended lower on Thursday, with semiconductor stocks leading

MILWAUKEE, July 16, 2026 /PRNewswire/ -- Ademi LLP is investigating AtaiBeckley (Nasdaq: ATAI) for p

The Dow and Russell 2000 are higher today, while the S&P 500 and Nasdaq move lower alongside chip st

AtaiBeckley stock surges after a Bloomberg report said Eli Lilly is in talks for a potential acquisi

BALA CYNWYD, Pa., July 16, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the followi

Eli Lilly & Co. agreed to buy AtaiBeckley Inc. for as much as $3.8 billion, underscoring growing int

U.S. stocks mixed, Nasdaq falls 150 points. Abbott Labs beats Q2 estimates and raises guidance, sto

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale

U.S. stock futures declined on Thursday, as the Dow Jones, Nasdaq 100, and S&P 500 indices fell,

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) has agreed to be acquired by Eli Lilly and Co (NYSE:LLY) i

Wall Street looked set for a mixed open Thursday with further yo-yoing in technology stocks amidst a

Gainers AtaiBeckley (NASDAQ:ATAI) stock rose 34.3% to $7.2 during Thursday's pre-market session

11:50am: AI stocks out of favor Investors are still favoring stocks with little direct exposure to A

Eli Lilly has struck a deal to buy mental-health-focused AtaiBeckley for an initial $2.8 billion, co

Eli Lilly ​said on ‌Thursday it would ​acquire ​psychedelic drug developer ⁠AtaiBeckley ​for up ​to

Eli Lilly and Company (NYSE:LLY) and AtaiBeckley Inc. (NASDAQ:ATAI), a clinical-stage biopharmaceuti

Eli Lilly will acquire psychedelic drugmaker AtaiBeckley for $2.8 billion. AtaiBeckley is developing

AtaiBeckley's lead program, BPL-003, is designed to provide durable relief from treatment-resistant

AtaiBeckley shares soared 50% premarket on Thursday after a report that Eli Lilly was in talks to ac

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) has agreed to be acquired by Eli Lilly and Co (NYSE:LLY) i

AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC) has agreed to be acquired by Eli Lilly and Co (NYSE:LLY) i

JB Hunt Transport Services Inc (JBHT) beat earnings and revenue estimates, causing shares to surge 7

AtaiBeckley shares jumped 64.70% after hours following reports that Eli Lilly is in talks to acquire

Eli Lilly is ​in talks ‌to acquire psychedelic drugmaker AtaiBeckley , ​and ​a deal could ⁠be announ

Psychedelic drug developers including AtaiBeckley Inc. (NASDAQ:ATAI, XETRA:9VC), Compass Pathways (N

Canaccord Genuity analyst Sumant Kulkarni maintains AtaiBeckley (NASDAQ:ATAI) with a Buy and rais

AtaiBeckley Inc. (NASDAQ:ATAI) ("AtaiBeckley" or "Company"), a clinical-stage biotec

The Russell U.S. Indexes have approximately $12.2 trillion in assets benchmarkedInclusion expands At

Health officials explored restricting specific antidepressants among SSRI drugs-sources